Pediatric Hematology/Oncology

The Division of Pediatric Hematology/Oncology cares for children and families afflicted with childhood blood disorders and cancers. The Division is led by Dr. Sujit Sheth and includes physicians, nurses, child life specialists, social workers, genetic counselors, technicians and post-doctoral fellows as well as a full administrative team. Affiliated with top-ranked NewYork-Presbyterian Phyllis and David Komansky Children's Hospital at Weill Cornell Medical Center, the Division provides family-centered care in our state of the art hematology/oncology facility at Payson 695 (6th Floor).

The Division provides comprehensive medical and professional services to over one thousand children and their families in both inpatient and outpatient services. Twenty-four hour emergency service is available.

Leaders in Research
The scientific faculty conducts basic research to identify and develop new medications and curative strategies for childhood blood disorders and cancers. The ACGME-accredited fellowship program conducted in collaboration with the Memorial Sloan Kettering Cancer Center pediatric program graduates seven board eligible Pediatric Hematologists/Oncologists each year. In addition, our clinical faculty conduct and participate in clinical research trials to improve the management of childhood blood disorders and cancers.

New York Comprehensive Thalassemia Center
The New York Comprehensive Thalassemia Center, home to one of the largest thalassemia programs in the U.S., is designated as a hemoglobinopathy specialty center by the New York State Department of Health. We provide a full range of comprehensive thalassemia care services including onsite screening, diagnosis, counseling, treatment and support from a multidisciplinary team at the cutting-edge academic medical institution that is NewYork-Presbyterian/Weill Cornell Medicine. 
Learn more

Pediatric Myeloproliferative Neoplasm Program
The Pediatric Myeloproliferative Neoplasm Program at Weill Cornell seeks to gain knowledge regarding the causes and mechanisms of myeloproliferative neoplasms in children, with the goal of improving diagnosis, treatment, and quality of life for children living with these disorders, and their families.
Learn more